Cite Filings / PLSE / 0001193125-26-222151

Feed Companies Filings Check

Sign in

SCHEDULE 13D/A

Beneficial Ownership Report

PULSE BIOSCIENCES, INC. Filed 2026-05-13 Acc 0001193125-26-222151

Documents 1

SCHEDULE 13D/A Beneficial Ownership Report , xslSCHEDULE_13D_X02/primary_doc.xml

Around this filing

2026-05-14 10-Q Quarterly Report
2026-05-13 SCHEDULE 13D/A Beneficial Ownership Report
2026-05-11 4/A Chief Executive Officer bought 15,000 shares at $19.69 ($295,350)
2026-05-11 4 Chief Executive Officer bought 15,000 shares at $19.69 ($295,350)
2026-05-11 4 Director bought 660,233 shares at $19.69 ($12,999,988)
2026-05-11 DEF 14A Proxy Statement
2024-12-19 SCHEDULE 13D/A Beneficial Ownership Report

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13D_X02/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…